Structural Requirements of the ASBT by 3D-QSAR Analysis Using Aminopyridine Conjugates of Chenodeoxycholic Acid
- 22 October 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 21 (11) , 2038-2048
Abstract
The human apical sodium-dependent bile acid transporter (ASBT) is a validated drug target and can be employed to increase oral bioavailability of various drug conjugates. The aim of the present study was to investigate the chemical space around the 24-position of bile acids that influences both inhibition and uptake by the transporter. A series of 27 aminopyridine and aminophenol conjugates of glutamyl-chenodeoxycholate were synthesized and their ASBT inhibition and transport kinetics (parametrized as Ki, Kt, and Jmax) measured using stably transfected ASBT-MDCK cells. All conjugates were potent ASBT inhibitors. Monoanionic conjugates exhibited higher inhibition potency than neutral conjugates. However, neutral conjugates and chloro-substituted monoanionic conjugates were not substrates, or at least not apparent substrates. Kinetic analysis of substrates indicated that similar values for Ki and Kt implicate substrate binding to ASBT as the rate-limiting step. Using 3D-QSAR, four inhibition models and one transport efficiency model were developed. Steric fields dominated in CoMFA models, whereas hydrophobic fields dominated CoMSIA models. The inhibition models showed that a hydrophobic or bulky substitute on the 2 or 6 position of a 3-aminopyridine ring enhanced activity, while a hydrophobic group on the 5 position was detrimental. Overall, steric and hydrophobic features around the 24 position of the sterol nucleus strongly influenced bile acid conjugate interaction with ASBT. The relative location of the pyridine nitrogen and substituent groups also modulated binding.Keywords
This publication has 29 references indexed in Scilit:
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Bile acid transportersJournal of Lipid Research, 2009
- Computational Models for Drug Inhibition of the Human Apical Sodium-Dependent Bile Acid TransporterMolecular Pharmaceutics, 2009
- Inhibition Requirements of the Human Apical Sodium-Dependent Bile Acid Transporter (hASBT) Using Aminopiperidine Conjugates of glutamyl-Bile AcidsPharmaceutical Research, 2009
- Method to Screen Substrates of Apical Sodium-Dependent Bile Acid TransporterThe AAPS Journal, 2008
- Impact of Impurity on Kinetic Estimates from Transport and Inhibition StudiesThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Bias in Estimation of Transporter Kinetic Parameters from Overexpression Systems: Interplay of Transporter Expression Level and Substrate AffinityThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Interaction of Native Bile Acids with Human Apical Sodium-Dependent Bile Acid Transporter (hASBT): Influence of Steroidal Hydroxylation Pattern and C-24 ConjugationPharmaceutical Research, 2006
- Apical Sodium Dependent Bile Acid Transporter (ASBT, SLC10A2): A Potential Prodrug TargetMolecular Pharmaceutics, 2006
- Influence of Charge and Steric Bulk in the C-24 Region on the Interaction of Bile Acids with Human Apical Sodium-Dependent Bile Acid TransporterMolecular Pharmaceutics, 2006